Serving Australia and NZ
1300 543 373
Return to Previous Page

Rat TGF-beta1 Platinum ELISA 2 x 96 tests

Rat TGF-beta1 Platinum ELISA 2 x 96 tests

Quick Overview:

Rat TGF-beta1 Platinum ELISA 2 x 96 tests

Product Code: BMS623/3TWO

  • Details

    The rat TGF-beta1 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of rat TGF-beta1. The rat TGF-beta 1 ELISA is for research use only. Not for diagnostic or therapeutic procedures.

    TGF-beta plays a critical role in cellular growth, development, differentiation, proliferation, extracellular matrix (ECM) synthesis and degradation, control of mesenchymal-epithelial interactions during embryogenesis, immune modulation, apoptosis, cell cycle progression, angiogenesis, adhesion and migration and leukocyte chemotaxis. It has both tumor suppressive and tumor promoting activities and is highly regulated at all levels. TGF-beta1 is the key mediator in the pathophysiology of tissue repair and human fibrogenesis: balance between production and degradation of type I collagen, and fibrosis and scarring in organ and tissue. TGF-beta1 promotes Treg cell differentiation resulting in IL-10/TGF-beta1 production and Th1 cell and Th2 cell suppression.
  • Additional Information

    SKU BMS623/3TWO
    Name Rat TGF-beta1 Platinum ELISA 2 x 96 tests
    Size 2 x 96 tests
    Product Type Platinum ELISAs
    Datasheet View Datasheet
    Supplier eBioscience
    Applications ELISA
    Species reactivity (expected) Rat
    General Readings Chopra,V.; Dinh,T.V.; Hannigan,E.V.. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 1998;16:152-159. (Link)

    Matsubara,T.; Umezawa,Y.; Tsuru,S.; Motohashi,T.; Yabuta,K.; Furukawa,S.. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand.J.Rheumatol. 1997;26:314-317. (Link)

    Kim,J.S.; Yoon,S.S.; Kim,Y.H.; Ryu,J.S.. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996;27:1553-1557. (Link)

    Langdahl,B.L.; Knudsen,J.Y.; Jensen,H.K.; Gregersen,N.; Eriksen,E.F.. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997;20:289-294. (Link)

    Matsubara,T.; Umezawa,Y.; Tsuru,S.; Motohashi,T.; Yabuta,K.; Furukawa,S.. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand.J Rheumatol 1997;26:314-317. (Link)

    Martyre,M.C.; Magdelenat,H.; Bryckaert,M.C.; Laine-Bidron,C.; Calvo,F.. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br.J Haematol. 1991;77:80-86. (Link)

    Finch,C.E.; Laping,N.J.; Morgan,T.E.; Nichols,N.R.; Pasinetti,G.M.. TGF-beta 1 is an organizer of responses to neurodegeneration. J.Cell Biochem. 1993;53:314-322. (Link)

    Bayer,E.M.; Herr,W.; Kanzler,S.; Waldmann,C.; Meyer Zum Buschenfelde,K.H.; Dienes,H.P.; Lohse,A.W.. Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J.Hepatol. 1998;28:803-811. (Link)

    Bayer,E.M.; Herr,W.; Kanzler,S.; Waldmann,C.; Meyer Zum Buschenfelde,K.H.; Dienes,H.P.; Lohse,A.W.. Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol. 1998;28:803-811. (Link)

    Carrieri,P.B.; Provitera,V.; Bruno,R.; Perrella,M.; Tartaglia,G.; Busto,A.; Perrella,O.. Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis. Neurol.Res. 1997;19:599-600. (Link)

    Wolff,J.M.; Fandel,T.; Borchers,H.; Brehmer,B.,Jr.; Jakse,G.. Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasia. Br.J.Urol. 1998;81:403-405. (Link)

    Lawrence,D.A.. Transforming growth factor-beta: a general review. Eur Cytokine Netw. 1996;7:363-374. (Link)

    Pfeilschifter,J.; Diel,I.; Scheppach,B.; Bretz,A.; Krempien,R.; Erdmann,J.; Schmid,G.; Reske,N.; Bismar,H.; Seck,T.; Krempien,B.; Ziegler,R.. Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J.Bone Miner.Res. 1998;13:716-730. (Link)

    Kropf,J.; Schurek,J.O.; Wollner,A.; Gressner,A.M.. Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison.. Clin.Chem. 1997;43:1965-1974. (Link)

    Tornquist,S.J.; Oaks,J.L.; Crawford,T.B.. Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia. J.Gen.Virol. 1997;78 ( Pt 10:2541-2548. (Link)

    Chao,C.C.; Janoff,E.N.; Hu,S.X.; Thomas,K.; Gallagher,M.; Tsang,M.; Peterson,P.K.. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991;3:292-298. (Link)

    Del,Giudice G.; Crow,M.K.. Role of transforming growth factor beta (TGF beta) in systemic autoimmunity. Lupus 1993;2:213-220. (Link)

    Astiz,M.; Saha,D.; Lustbader,D.; Lin,R.; Rackow,E.. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin.Med 1996;128:594-600. (Link)

    Muller,F.; Aukrust,P.; Nilssen,D.E.; Froland,S.S.. Reduced serum level of transforming growth factor-beta in patients with IgA deficiency. Clin.Immunol.Immunopathol. 1995;76:203-208. (Link)

    Shankland,S.J.; Johnson,R.J.. TGF-beta in glomerular disease. Miner.Electrolyte Metab 1998;24:168-173. (Link)

    Mattson,M.P.; Barger,S.W.; Furukawa,K.; Bruce,A.J.; Wyss-Coray,T.; Mark,R.J.; Mucke,L.. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res.Brain Res.Rev. 1997;23:47-61. (Link)

    Border,W.A.. Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr.Opin.Nephrol.Hypertens. 1994;3:54-58. (Link)

    Flanders,K.C.; Ren,R.F.; Lippa,C.F.. Transforming growth factor-betas in neurodegenerative disease. Prog.Neurobiol. 1998;54:71-85. (Link)

    Murawaki,Y.; Ikuta,Y.; Nishimura,Y.; Koda,M.; Kawasaki,H.. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis. J Gastroenterol.Hepatol. 1996;11:443-450. (Link)

    Zauli,G.; Gugliotta,L.; Catani,L.; Vianelli,N.; Borgatti,P.; Belmonte,M.M.; Tura,S.. Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis. Br.J.Haematol. 1993;84:381-386. (Link)